Executive Summary
Azoth Analytics has released a research report titled "Incretin Based Drugs Market (2023 Edition)" which provides a complete analysis of the global Incretin Based Drugs industry in terms of market segmentation By Drug Type (Glucagon-like Peptide-1 Receptor Agonists, Dipeptidyl Peptidase-4 Inhibitors), By Route of Administration (Oral, Injectables) and By Indication (Diabetes, Obesity) for the historical period of 2018-2022, the estimated year of 2023 and the forecast period of 2024-2028.
The research report covers a detailed analysis of the regions (Americas, Europe, APAC, Middle East Africa) and 10 countries (United States, Canada, Germany, United Kingdom, France, Italy, Spain, China, Japan, India). Additionally, the research report presents data including market size, yearly growth & potential analysis, the competitive study of market players, investment opportunities and demand forecast. The research also assesses growth indicators, restraints, supply and demand risk, and other important statistics, as well as a full assessment of current and future market trends that are relevant to the market's evolution.
During the forecast period, 2024-2029, the Global Incretin Based Drugs market is expected to grow at a CAGR of 6.8%. The Global Incretin Based Drugs Market is expected to generate USD 64.28 billion by the end of 2029, up from USD 40.72 Billion in 2022.
Incretin-based drugs are the first-of-its-kind anti-hyperglycemic medications that have been developed by specifically targeting a recognized pathophysiological abnormality in type 2 diabetes. The global increase in the prevalence of type 2 diabetes has a significant impact on the demand for incretin-based drugs. The growing incidence of diabetes can be attributed to various factors, including sedentary lifestyles, poor dietary habits, and the ageing demographic.
In comparison to many other anti-hyperglycemic medications, incretin-based drugs offer some notable benefits, including the lack of an elevated risk of hypoglycemia or weight gain. The DPP4Is and GLP-1RAs exhibit unique efficacy and tolerability profiles, providing physicians with the opportunity to choose the most suitable medication for each patient, taking into account factors such as disease status (as indicated by HbA1c percentage), body weight, and patient preference for self-administered injectable drugs. The demand for Incretin-based drugs is expected to grow exponentially as the blockbuster drugs in the market become accessible in generic form and as upgraded formulations with reduced dosing frequency are introduced.
Scope of the Report
- The report analyses the Incretin Based Drugs Market by Value (USD Billion).
- The report presents the analysis of Incretin Based Drugs Market for the historical period of 2019-2022, the estimated year 2023 and the forecast period of 2024-2029.
- The report analyses the Incretin-Based Drugs Market by Drug Type (Glucagon-like Peptide-1 Receptor Agonists, Dipeptidyl Peptidase-4 Inhibitors).
- The report analyses the Incretin Based Drugs Market by Route of Administration (Oral, Injectables)
- The report analyses the Incretin-Based Drugs Market by Indication (Diabetes, Obesity).
- The key insights of the report have been presented through the frameworks of SWOT and Porter's Five Forces Analysis. Also, the attractiveness of the market has been presented by region, By Drug Type, By Route of Administration and by Indications.
- Also, the major opportunities, trends, drivers, and challenges of the industry have been analyzed in the report.
- The report tracks competitive developments, strategies, mergers and acquisitions and new product development. The companies analysed in the report include Eli Lilly and Company, Boehringer Ingelheim, Novo Nordisk, AstraZeneca PLC, Merck & Co., Inc., Pfizer, Novartis AG, Takeda Pharmaceuticals, Bristol Myers Squibb, Structure Therapeutics.
Global Incretin Based Drugs Market (2023 Edition): Analysis By Drug Type (Glucagon-like Peptide-1 Receptor Agonists, Dipeptidyl Peptidase-4 Inhibitors), Route of Administration, By Indication, By Region, By Country: Market Insights and Forecast (2019-2029)
Table of Contents
1. Market Background
1.1 Scope and Product Outlook
1.2 Executive Summary
1.3 Research Methodology
2. Strategic Recommendations
3. Global Incretin Based Drugs Market: Historic and Forecast (2018-2028)
3.1 Global Obesity Statistics 2022, in Millions
3.2 Pipeline Analysis of Incretin based drugs
3.3 Countries with the highest prevalence of diabetes worldwide in 2021
3.4 Estimated number of individuals with Diabetes Worldwide, in thousands (2000-2014E)
3.5 Global Incretin-Based Drugs Market: Dashboard
3.6 Global Incretin Based Drugs Market: Market Value Assessment, 2018-2028 (USD Billion)
3.7 Impact of COVID-19 on Global Incretin Based Drugs Market
3.8 Global Incretin-Based Drugs Market Segmentation: By Drug Type
3.8.1 Global Incretin-Based Drugs Market, By Drug Type Overview
3.8.2 Global Incretin Based Drugs Market Size, By Glucagon-like Peptide-1 Receptor Agonists, By Value, 2018H-2028F (USD Billion & CAGR)
3.8.3 Global Incretin Based Drugs Market Size, By Dipeptidyl Peptidase-4 Inhibitors, By Value, 2018H-2028F (USD Billion & CAGR)
3.9 Global Incretin-Based Drugs Market Segmentation: By Route of Administration
3.9.1 Global Incretin-Based Drugs Market, By Route of Administration Overview
3.9.2 Global Incretin-Based Drugs Market Size, By Oral, By Value, 2018H-2028F (USD Billion & CAGR)
3.9.3 Global Incretin-Based Drugs Market Size, By Injectables, By Value, 2018H-2028F (USD Billion & CAGR)
3.10 Global Incretin Based Drugs Market Segmentation: By Indication
3.10.1 Global Incretin Based Drugs Market, By Indication Overview
3.10.2 Global Incretin Based Drugs Market Size, By Diabetes By Value, 2018H-2028F (USD Billion & CAGR)
3.10.3 Global Incretin Based Drugs Market Size, By Obesity, By Value, 2018H-2028F (USD Billion & CAGR)
4. Global Incretin Based Drugs Market, Region Analysis
4.1 Regional Coverage of the Study
4.2 Regional Snapshot
5. Americas Incretin Based Drugs Market: Historic and Forecast (2018-2028)
5.1 Americas Incretin-Based Drugs Market: Snapshot
5.2 Americas Incretin-Based Drugs Market: Market Size and CAGR, 2018-2028 (USD Billion & CAGR)
5.3 Americas Incretin-Based Drugs Market: Key Factors
5.4 Americas Incretin-Based Drugs Market: Segment Analysis
5.5 Americas Incretin-Based Drugs Market Segmentation: By Drug Type
5.5.1 Americas Incretin-Based Drugs Market, By Drug Type Overview
5.5.2 Americas Incretin Based Drugs Market Size, By Glucagon-like Peptide-1 Receptor Agonists, By Value, 2018H-2028F (USD Billion & CAGR)
5.5.3 Americas Incretin Based Drugs Market Size, By Dipeptidyl Peptidase-4 Inhibitors, By Value, 2018H-2028F (USD Billion & CAGR)
5.6 Americas Incretin-Based Drugs Market Segmentation: By Route of Administration
5.6.1 Americas Incretin-Based Drugs Market, By Route of Administration Overview
5.6.2 Americas Incretin-Based Drugs Market Size, By Oral, By Value, 2018H-2028F (USD Billion & CAGR)
5.6.3 Americas Incretin-Based Drugs Market Size, By Injectables, By Value, 2018H-2028F (USD Billion & CAGR)
5.7 Americas Incretin-Based Drugs Market Segmentation: By Indication
5.7.1 Americas Incretin-Based Drugs Market, By Indication Overview
5.7.2 Americas Incretin-Based Drugs Market Size, By Diabetes, By Value, 2018H-2028F (USD Billion & CAGR)
5.7.3 Americas Incretin-Based Drugs Market Size, By Obesity, By Value, 2018H-2028F (USD Billion & CAGR)
5.8 Americas Incretin-Based Drugs Market Segmentation: By Country
5.8.1 United States Incretin-Based Drugs Market: Market Size and CAGR, 2018-2028 (USD Billion & CAGR)
5.8.1.1 United States Incretin-Based Drugs Market, By Drug Type
5.8.1.2 United States Incretin-Based Drugs Market, By Route of Administration
5.8.1.3 United States Incretin-Based Drugs Market, By Indication
5.8.2 Canada Incretin-Based Drugs Market: Market Size and CAGR, 2018-2028 (USD Billion & CAGR)
5.8.2.1 Canada Incretin-Based Drugs Market, By Drug Type
5.8.2.2 Canada Incretin-Based Drugs Market, By Route of Administration
5.8.2.3 Canada Incretin-Based Drugs Market, By Indication
5.8.3 Rest of Americas Incretin-Based Drugs Market: Market Size and CAGR, 2018-2028 (USD Billion & CAGR)
5.8.3.1 Rest of Americas Incretin-Based Drugs Market, By Drug Type
5.8.3.2 Rest of Americas Incretin-Based Drugs Market, By Route of Administration
5.8.3.3 Rest of Americas Incretin-Based Drugs Market, By Indication
6. Europe Incretin Based Drugs Market: Historic and Forecast (2018-2028)
6.1 Europe Incretin-Based Drugs Market: Snapshot
6.2 Europe Incretin-Based Drugs Market: Market Size and CAGR, 2018-2028 (USD Billion & CAGR)
6.3 Europe Incretin-Based Drugs Market: Key Factors
6.4 Europe Incretin-Based Drugs Market: Segment Analysis
6.5 Europe Incretin-Based Drugs Market Segmentation: By Drug Type
6.5.1 Europe Incretin-Based Drugs Market, By Drug Type Overview
6.5.2 Europe Incretin Based Drugs Market Size, By Glucagon-like Peptide-1 Receptor Agonists, By Value, 2018H-2028F (USD Billion & CAGR)
6.5.3 Europe Incretin Based Drugs Market Size, By Dipeptidyl Peptidase-4 Inhibitors, By Value, 2018H-2028F (USD Billion & CAGR)
6.6 Europe Incretin-Based Drugs Market Segmentation: By Route of Administration
6.6.1 Europe Incretin-Based Drugs Market, By Route of Administration Overview
6.6.2 Europe Incretin-Based Drugs Market Size, By Oral, By Value, 2018H-2028F (USD Billion & CAGR)
6.6.3 Europe Incretin-Based Drugs Market Size, By Injectables, By Value, 2018H-2028F (USD Billion & CAGR)
6.7 Europe Incretin-Based Drugs Market Segmentation: By Indication
6.7.1 Europe Incretin-Based Drugs Market, By Indication Overview
6.7.2 Europe Incretin-Based Drugs Market Size, By Diabetes, By Value, 2018H-2028F (USD Billion & CAGR)
6.7.3 Europe Incretin-Based Drugs Market Size, By Obesity, By Value, 2018H-2028F (USD Billion & CAGR)
6.8 Europe Incretin-Based Drugs Market Segmentation: By Country
6.8.1 Germany Incretin-Based Drugs Market: Market Size and CAGR, 2018-2028 (USD Billion & CAGR)
6.8.1.1 Germany Incretin-Based Drugs Market, By Drug Type
6.8.1.2 Germany Incretin Based Drugs Market, By Route of Administration
6.8.1.3 Germany Incretin Based Drugs Market, By Indication
6.8.2 United Kingdom Incretin Based Drugs Market: Market Size and CAGR, 2018-2028 (USD Billion & CAGR)
6.8.2.1 United Kingdom Incretin Based Drugs Market, By Drug Type
6.8.2.2 United Kingdom Incretin Based Drugs Market, By Route of Administration
6.8.2.3 United Kingdom Incretin Based Drugs Market, By Indication
6.8.3 France Incretin Based Drugs Market: Market Size and CAGR, 2018-2028 (USD Billion & CAGR)
6.8.3.1 France Incretin Based Drugs Market, By Drug Type
6.8.3.2 France Incretin Based Drugs Market, By Route of Administration
6.8.3.3 France Incretin Based Drugs Market, By Indication
6.8.4 Italy Incretin Based Drugs Market: Market Size and CAGR, 2018-2028 (USD Billion & CAGR)
6.8.4.1 Italy Incretin Based Drugs Market, By Drug Type
6.8.4.2 Italy Incretin Based Drugs Market, By Route of Administration
6.8.4.3 Italy Incretin Based Drugs Market, By Indication
6.8.5 Spain Incretin Based Drugs Market: Market Size and CAGR, 2018-2028 (USD Billion & CAGR)
6.8.5.1 Spain Incretin Based Drugs Market, By Drug Type
6.8.5.2 Spain Incretin Based Drugs Market, By Route of Administration
6.8.5.3 Spain Incretin Based Drugs Market, By Indication
6.8.6 Rest of Europe Incretin-Based Drugs Market: Market Size and CAGR, 2018-2028 (USD Billion & CAGR)
6.8.6.1 Rest of Europe Incretin-Based Drugs Market, By Drug Type
6.8.6.2 Rest of Europe Incretin-Based Drugs Market, By Route of Administration
6.8.6.3 Rest of Europe Incretin-Based Drugs Market, By Indication
7. Asia-Pacific Incretin Based Drugs Market: Historic and Forecast (2018-2028)
7.1 Asia-Pacific Incretin Based Drugs Market: Snapshot
7.2 Asia-Pacific Incretin Based Drugs Market: Market Size and CAGR, 2018-2028 (USD Billion & CAGR)
7.3 Asia-Pacific Incretin Based Drugs Market: Key Factors
7.4 Asia-Pacific Incretin Based Drugs Market: Segment Analysis
7.5 Asia-Pacific Incretin Based Drugs Market Segmentation: By Drug Type
7.5.1 Asia-Pacific Incretin Based Drugs Market, By Drug Type Overview
7.5.2 Asia-Pacific Incretin Based Drugs Market Size, By Glucagon-like Peptide-1 Receptor Agonists, By Value, 2018H-2028F (USD Billion & CAGR)
7.5.3 Asia-Pacific Incretin Based Drugs Market Size, By Dipeptidyl Peptidase-4 Inhibitors, By Value, 2018H-2028F (USD Billion & CAGR)
7.6 Asia-Pacific Incretin Based Drugs Market Segmentation: By Route of Administration
7.6.1 Asia-Pacific Incretin Based Drugs Market, By Route of Administration Overview
7.6.2 Asia-Pacific Incretin Based Drugs Market Size, By Oral, By Value, 2018H-2028F (USD Billion & CAGR)
7.6.3 Asia-Pacific Incretin Based Drugs Market Size, By Injectables, By Value, 2018H-2028F (USD Billion & CAGR)
7.7 Asia-Pacific Incretin Based Drugs Market Segmentation: By Indication
7.7.1 Asia-Pacific Incretin Based Drugs Market, By Indication Overview
7.7.2 Asia-Pacific Incretin Based Drugs Market Size, By Diabetes, By Value, 2018H-2028F (USD Billion & CAGR)
7.7.3 Asia-Pacific Incretin Based Drugs Market Size, By Obesity, By Value, 2018H-2028F (USD Billion & CAGR)
7.8 Asia-Pacific Incretin Based Drugs Market Segmentation: By Country
7.8.1 China Incretin Based Drugs Market: Market Size and CAGR, 2018-2028 (USD Billion & CAGR)
7.8.1.1 China Incretin Based Drugs Market, By Drug Type
7.8.1.2 China Incretin Based Drugs Market, By Route of Administration
7.8.1.3 China Incretin Based Drugs Market, By Indication
7.8.2 Japan Incretin Based Drugs Market: Market Size and CAGR, 2018-2028 (USD Billion & CAGR)
7.8.1.1 Japan Incretin Based Drugs Market, By Drug Type
7.8.1.2 Japan Incretin Based Drugs Market, By Route of Administration
7.8.1.3 Japan Incretin Based Drugs Market, By Indication
7.8.3 India Incretin Based Drugs Market: Market Size and CAGR, 2018-2028 (USD Billion & CAGR)
7.8.3.1 India Incretin Based Drugs Market, By Drug Type
7.8.3.2 India Incretin Based Drugs Market, By Route of Administration
7.8.3.3 India Incretin Based Drugs Market, By Indication
7.8.5 Rest of Asia-Pacific Incretin Based Drugs Market: Market Size and CAGR, 2018-2028 (USD Billion & CAGR)
7.8.5.1 Rest of Asia-Pacific Incretin Based Drugs Market, By Drug Type
7.8.5.2 Rest of Asia-Pacific Incretin Based Drugs Market, By Route of Administration
7.8.5.3 Rest of Asia-Pacific Incretin Based Drugs Market, By Indication
8. Middle-East & Africa Incretin Based Drugs Market: Historic and Forecast (2018-2028)
8.1 Middle-East & Africa Incretin Based Drugs Market: Snapshot
8.2 Middle-East & Africa Incretin Based Drugs Market: Market Size and CAGR, 2018-2028 (USD Billion & CAGR)
8.3 Middle-East & Africa Incretin Based Drugs Market: Key Factors
8.4 Middle-East & Africa Incretin Based Drugs Market: Segment Analysis
8.5 Middle-East & Africa Incretin Based Drugs Market Segmentation: By Drug Type
8.5.1 Middle-East & Africa Incretin Based Drugs Market, By Drug Type Overview
8.5.2 Middle-East & Africa Incretin Based Drugs Market Size, By Glucagon-like Peptide-1 Receptor Agonists, By Value, 2018H-2028F (USD Billion & CAGR)
8.5.3 Middle-East & Africa Incretin Based Drugs Market Size, By Dipeptidyl Peptidase-4 Inhibitors, By Value, 2018H-2028F (USD Billion & CAGR)
8.6 Middle-East & Africa Incretin Based Drugs Market Segmentation: By Route of Administration
8.6.1 Middle-East & Africa Incretin Based Drugs Market, By Route of Administration Overview
8.6.2 Middle-East & Africa Incretin Based Drugs Market Size, By Oral, By Value, 2018H-2028F (USD Billion & CAGR)
8.6.3 Middle-East & Africa Incretin Based Drugs Market Size, By Injectables, By Value, 2018H-2028F (USD Billion & CAGR)
8.7 Middle-East & Africa Incretin Based Drugs Market Segmentation: By Indication
8.7.1 Middle-East & Africa Incretin Based Drugs Market, By Indication: Overview
8.7.2 Middle-East & Africa Incretin Based Drugs Market Size, By Diabetes, By Value, 2018H-2028F (USD Billion & CAGR)
8.7.3 Middle-East & Africa Incretin Based Drugs Market Size, By Obesity, By Value, 2018H-2028F (USD Billion & CAGR)
9. Market Dynamics
9.1 Impact Assessment of Market Dynamics on Global Incretin-Based Drugs Market
9.2 Drivers
9.3 Restraints
9.4 Trends
10. Porter's Five Forces Analysis
10.1 Porter's Five Forces Model
11. Competitive Positioning
11.1 Companies' Product Positioning
11.2 Market Position Matrix
11.3 Market Share Analysis of Incretin-Based Drugs Market
11.4 Company Profiles
11.4.1 Eli Lilly and Company
11.4.2 Boehringer Ingelheim
11.4.3 Novo Nordisk
11.4.4 AstraZeneca PLC
11.4.5 Merck & Co., Inc.
11.4.6 Pfizer
11.4.7 Novartis AG
11.4.8 Takeda Pharmaceuticals
11.4.9 Bristol Myers Squibb
11.4.10 Structure Therapeutics
List of Figures
Figure 1: Global obesity statistics 2022(In Millions)
Figure 2: Countries with the highest prevalence of diabetes worldwide in 2021
Figure 3: People with diabetes in Thousands, (20-79 y)
Figure 4: Global Incretin Based Drugs Market Size, By Value, 2019-2022 (USD Billion)
Figure 5: Global Incretin Based Drugs Market Size, By Value, 2023-2029 (USD Billion)
Figure 6: Global Incretin Based Drugs Market Share, By Drug Type, 2022 (%)
Figure 7: Global Incretin Based Drugs Market Size, By Glucagon-like Peptide-1 Receptor Agonists, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 8: Global Incretin Based Drugs Market Absolute Opportunity, By Glucagon-like Peptide-1 Receptor Agonists, 2019-2029 (USD Billion)
Figure 9: Global Incretin Based Drugs Market Size, By Dipeptidyl Peptidase-4 Inhibitors, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 10: Global Incretin Based Drugs Market Absolute Opportunity, By Dipeptidyl Peptidase-4 Inhibitors, 2019-2029 (USD Billion)
Figure 11: Global Incretin Based Drugs Market Size, By Oral, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 12: Global Incretin Based Drugs Market Absolute Opportunity, By Oral, 2019-2029 (USD Billion)
Figure 13: Global Incretin Based Drugs Market Size, By Injectables, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 14: Global Incretin Based Drugs Market Absolute Opportunity, By Injectables, 2019-2029 (USD Billion)
Figure 15: Global Incretin Based Drugs Market Size, By Diabetes, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 16: Global Incretin Based Drugs Market Absolute Opportunity, By Diabetes, 2019-2029 (USD Billion)
Figure 17: Global Incretin Based Drugs Market Size, By Obesity, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 18: Global Incretin Based Drugs Market Absolute Opportunity, By Obesity, 2019-2029 (USD Billion)
Figure 19: Americas Incretin Based Drugs Market Size, By Value, 2019H-2029F (USD Billion)
Figure 20: Americas Incretin Based Drugs Market Share, By Drug Type, 2022 (%)
Figure 21: Americas Incretin Based Drugs Market, By Glucagon-like Peptide-1 Receptor Agonists, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 22: Americas Incretin Based Drugs Market, By Dipeptidyl Peptidase-4 Inhibitors, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 23: Americas Incretin Based Drugs Market, By Oral, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 24: Americas Incretin Based Drugs Market, By Injectables, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 25: Americas Incretin Based Drugs Market, By Diabetes, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 26: Americas Incretin Based Drugs Market, By Obesity, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 27: United States Incretin Based Drugs Market, By Value, 2019-2029 (USD Billion & CAGR)
Figure 28: United States Incretin Based Drugs Market Value, By Drug Type, 2022 (USD Billion)
Figure 29: United States Incretin Based Drugs Market Share, By Drug Type, By Value, 2022 (%)
Figure 30: United States Incretin Based Drugs Market Share, By Route of Administration, By Value, 2022 (%)
Figure 31: United States Incretin Based Drugs Market Share, By Indication, 2022 (%)
Figure 32: Canada Incretin Based Drugs Market, By Value, 2019-2029 (USD Billion & CAGR)
Figure 33: Canada Incretin Based Drugs Market Value, By Drug Type, 2022 (USD Billion)
Figure 34: Canada Incretin Based Drugs Market Share, By Drug Type, By Value, 2022 (%)
Figure 35: Canada Incretin Based Drugs Market Share, By Route of Administration, 2022 (%)
Figure 36: Canada Incretin Based Drugs Market Share, Indication, 2022 (%)
Figure 37: Rest of Americas Incretin Based Drugs Market, By Value, 2019-2029 (USD Billion & CAGR)
Figure 38: Rest of Americas Incretin Based Drugs Market Value, By Drug Type, 2022 (USD Billion)
Figure 39: Rest of Americas Incretin Based Drugs Market Share, By Drug Type, By Value, 2022 (%)
Figure 40: Rest of Americas Incretin Based Drugs Market Share, By Route of Administration, 2022 (%)
Figure 41: Rest of Americas Incretin Based Drugs Market Share, By Indication, 2022 (%)
Figure 42: Europe Incretin Based Drugs Market Size, By Value, 2019H-2029F (USD Billion)
Figure 43: Europe Incretin Based Drugs Market Share, By Drug Type, 2022 (%)
Figure 44: Europe Incretin Based Drugs Market, By Glucagon-like Peptide-1 Receptor Agonists, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 45: Europe Incretin Based Drugs Market, By Dipeptidyl Peptidase-4 Inhibitors, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 46: Europe Incretin Based Drugs Market, By Oral, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 47: Europe Incretin Based Drugs Market, By Injectables, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 48: Europe Incretin Based Drugs Market, By Diabetes, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 49: Europe Incretin Based Drugs Market, By Obesity, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 50: Germany Incretin Based Drugs Market, By Value, 2019-2029 (USD Billion & CAGR)
Figure 51: Germany Incretin Based Drugs Market Value, By Drug Type, 2022 (USD Billion)
Figure 52: Germany Incretin Based Drugs Market Share, By Drug Type, By Value, 2022 (%)
Figure 53: Germany Incretin Based Drugs Market Share, By Route of Administration, By Value, 2022 (%)
Figure 54: Germany Incretin Based Drugs Market Share, By Indication, 2022 (%)
Figure 55: United Kingdom Incretin Based Drugs Market, By Value, 2019-2029 (USD Billion & CAGR)
Figure 56: United Kingdom Incretin Based Drugs Market Value, By Drug Type, 2022 (USD Billion)
Figure 57: United Kingdom Incretin Based Drugs Market Share, By Drug Type, By Value, 2022 (%)
Figure 58: United Kingdom Incretin Based Drugs Market Share, By Route of Administration, By Value, 2022 (%)
Figure 59: United Kingdom Incretin Based Drugs Market Share, By Indication, 2022 (%)
Figure 60: France Incretin Based Drugs Market, By Value, 2019-2029 (USD Billion & CAGR)
Figure 61: France Incretin Based Drugs Market Value, By Drug Type, 2022 (USD Billion)
Figure 62: France Incretin Based Drugs Market Share, By Drug Type, By Value, 2022 (%)
Figure 63: France Incretin Based Drugs Market Share, By Route of Administration, By Value, 2022 (%)
Figure 64: France Incretin Based Drugs Market Share, By Indication, 2022 (%)
Figure 65: Italy Incretin Based Drugs Market, By Value, 2019-2029 (USD Billion & CAGR)
Figure 66: Italy Incretin Based Drugs Market Value, By Drug Type, 2022 (USD Billion)
Figure 67: Italy Incretin Based Drugs Market Share, By Drug Type, By Value, 2022 (%)
Figure 68: Italy Incretin Based Drugs Market Share, By Route of Administration, 2022 (%)
Figure 69: Italy Incretin Based Drugs Market Share, By Indication, 2022 (%)
Figure 70: Spain Incretin Based Drugs Market, By Value, 2019-2029 (USD Billion & CAGR)
Figure 71: Spain Incretin Based Drugs Market Value, By Drug Type, 2022 (USD Billion)
Figure 72: Spain Incretin Based Drugs Market Share, By Drug Type, By Value, 2022 (%)
Figure 73: Spain Incretin Based Drugs Market Share, By Route of Administration, 2022 (%)
Figure 74: Spain Incretin Based Drugs Market Share, By Indication, 2022 (%)
Figure 75: Rest of Europe Incretin Based Drugs Market, By Value, 2019-2029 (USD Billion & CAGR)
Figure 76: Rest of Europe Incretin Based Drugs Market Value, By Drug Type, 2022 (USD Billion)
Figure 77: Rest of Europe Incretin Based Drugs Market Share, By Drug Type, By Value, 2022 (%)
Figure 78: Rest of Europe Incretin Based Drugs Market Share, By Route of Administration, 2022 (%)
Figure 79: Rest of Europe Incretin Based Drugs Market Share, By Indication, 2022 (%)
Figure 80: Asia Pacific Incretin Based Drugs Market Size, By Value, 2019H-2029F (USD Billion)
Figure 81: Asia Pacific Incretin Based Drugs Market Share, By Drug Type, 2022 (%)
Figure 82: Asia Pacific Incretin Based Drugs Market, By Glucagon-like Peptide-1 Receptor Agonists, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 83: Asia Pacific Incretin Based Drugs Market, By Dipeptidyl Peptidase-4 Inhibitors, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 84: Asia Pacific Incretin Based Drugs Market, By Oral, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 85: Asia Pacific Incretin Based Drugs Market, By Injectables, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 86: Asia Pacific Incretin Based Drugs Market, By Diabetes, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 87: Asia Pacific Incretin Based Drugs Market, By Obesity, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 88: China Incretin Based Drugs Market, By Value, 2019-2029 (USD Billion & CAGR)
Figure 89: China Incretin Based Drugs Market Value, By Drug Type, 2022 (USD Billion)
Figure 90: China Incretin Based Drugs Market Share, By Drug Type, By Value, 2022 (%)
Figure 91: China Incretin Based Drugs Market Share, By Route of Administration, 2022 (%)
Figure 92: China Incretin Based Drugs Market Share, By Indication, 2022 (%)
Figure 93: Japan Incretin Based Drugs Market, By Value, 2019-2029 (USD Billion & CAGR)
Figure 94: Japan Incretin Based Drugs Market Value, By Drug Type, 2022 (USD Billion)
Figure 95: Japan Incretin Based Drugs Market Share, By Drug Type, By Value, 2022 (%)
Figure 96: Japan Incretin Based Drugs Market Share, By Route of Administration, 2022 (%)
Figure 97: Japan Incretin Based Drugs Market Share, By Indication, 2022 (%)
Figure 98: India Incretin Based Drugs Market, By Value, 2019-2029 (USD Billion & CAGR)
Figure 99: India Incretin Based Drugs Market Value, By Drug Type, 2022 (USD Billion)
Figure 100: India Incretin Based Drugs Market Share, By Drug Type, By Value, 2022 (%)
Figure 101: India Incretin Based Drugs Market Share, By Route of Administration, 2022 (%)
Figure 102: India Incretin Based Drugs Market Share, By Indication, 2022 (%)
Figure 103: Rest of Asia Pacific Incretin Based Drugs Market, By Value, 2019-2029 (USD Billion & CAGR)
Figure 104: Rest of Asia Pacific Incretin Based Drugs Market Value, By Drug Type, 2022 (USD Billion)
Figure 105: Rest of Asia Pacific Incretin Based Drugs Market Share, By Drug Type, By Value, 2022 (%)
Figure 106: Rest of Asia Pacific Incretin Based Drugs Market Share, By Route of Administration, 2022 (%)
Figure 107: Rest of Asia Pacific Incretin Based Drugs Market Share, By Indication, 2022 (%)
Figure 108: Middle East and Africa Incretin Based Drugs Market Size, By Value, 2019H-2029F (USD Billion)
Figure 109: Middle East and Africa Incretin Based Drugs Market Share, By Drug Type, 2022 (%)
Figure 110: Middle East and Africa Incretin Based Drugs Market, By Glucagon-like Peptide-1 Receptor Agonists, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 111: Middle East and Africa Incretin Based Drugs Market, By Dipeptidyl Peptidase-4 Inhibitors, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 112: Middle East and Africa Incretin Based Drugs Market, By Oral, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 113: Middle East and Africa Incretin Based Drugs Market, By Injectables, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 114: Middle East and Africa Incretin Based Drugs Market, By Diabetes, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 115: Middle East and Africa Incretin Based Drugs Market, By Obesity, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 116: Market Share of Prominent Companies of Incretin Based Drugs Market, 2022 (%)
Figure 117: Eli Lilly and Company Revenues, 2020-2022 (USD Million)
Figure 118: Eli Lilly and Company Revenues, By Geographic Segments, 2022 (%)
Figure 119: Eli Lilly and Company Revenue, By Therapeutic Area, 2022 (%)
Figure 120: Novo Nordisk Revenues, 2020-2022 (USD Million)
Figure 121: Novo Nordisk Revenues, By Geographic Segments, 2022 (%)
Figure 122: Novo Nordisk Revenue, By Therapeutic Area, 2022 (%)
Figure 123: AstraZeneca PLC Revenues, 2020-2022 (USD Million)
Figure 124: AstraZeneca PLC Revenues, By Geographic Segments, 2022 (%)
Figure 125: AstraZeneca PLC Revenue, By Business Segments, 2022 (%)
Figure 126: Merck & Co., Inc. Revenues, 2020-2022 (USD Million)
Figure 127: Merck & Co., Inc. Revenues, By Geographic Segments, 2022 (%)
Figure 128: Merck & Co., Inc. Revenue, By Business Segments, 2022 (%)
Figure 129: Pfizer Revenues, 2020-2022 (USD Million)
Figure 130: Pfizer Revenues, By Business Segments, 2022 (%)
Figure 131: Pfizer Inc. Revenue, By Geographical Segments, 2022 (%)
Figure 132: Novartis Revenue, 2020-2022 (USD Million)
Figure 133: Novartis Revenue, By Business Segments, 2022 (%)
Figure 134: Novartis Revenue, By Geographical Segments, 2022 (%)
Figure 135: Takeda Pharmaceuticals Revenues, 2019-2021 (USD Million)
Figure 136: Takeda Pharmaceuticals Revenues, By Geographic Segments, 2021 (%)
Figure 137: Takeda Pharmaceuticals Revenue, By Business Segments, 2021 (%)
Figure 138: Bristol-Myers Squibb Revenues, 2020-2022 (USD Million)
Figure 139: Bristol-Myers Squibb Revenues, By Geographic Segments, 2022 (%)
List of Tables
Table A1: Incretin based drugs in Several stages of clinical trials
Table A2: United States Incretin Based Drugs Market, By Drug Type, By Value, 2019-2022 (USD Billion)
Table A3: United States Incretin Based Drugs Market, By Drug Type, By Value, 2023-2029 (USD Billion)
Table A4: United States Incretin Based Drugs Market, By Route of Administration, By Value, 2019-2022 (USD Billion)
Table A5: United States Incretin Based Drugs Market, By Route of Administration, By Value, 2023-2029 (USD Billion)
Table A6: United States Incretin Based Drugs Market, By Indication, By Value, 2019-2022 (USD Billion)
Table A7: United States Incretin Based Drugs Market, By Indication, By Value, 2023-2029 (USD Billion)
Table A8: Canada Incretin Based Drugs Market, By Drug Type, By Value, 2019-2022 (USD Billion)
Table A9: Canada Incretin Based Drugs Market, By Drug Type, By Value, 2023-2029 (USD Billion)
Table A10: Canada Incretin Based Drugs Market, By Route of Administration, By Value, 2019-2022 (USD Billion)
Table A11: Canada Incretin Based Drugs Market, By Route of Administration, By Value, 2023-2029 (USD Billion)
Table A12: Canada Incretin Based Drugs Market, By Indication, By Value, 2019-2022 (USD Billion)
Table A13: Canada Incretin Based Drugs Market, By Indication, By Value, 2023-2029 (USD Billion)
Table A14: Rest of Americas Incretin Based Drugs Market, By Drug Type, By Value, 2019-2022 (USD Billion)
Table A15: Rest of Americas Incretin Based Drugs Market, By Drug Type, By Value, 2023-2029 (USD Billion)
Table A16: Rest of Americas Incretin Based Drugs Market, By Route of Administration, By Value, 2019-2022 (USD Billion)
Table A17: Rest of Americas Incretin Based Drugs Market, By Route of Administration, By Value, 2023-2029 (USD Billion)
Table A18: Rest of Americas Incretin Based Drugs Market, By Indication, By Value, 2019-2022 (USD Billion)
Table A19: Rest of Americas Incretin Based Drugs Market, By Indication, By Value, 2023-2029 (USD Billion)
Table A20: Germany Incretin Based Drugs Market, By Drug Type, By Value, 2019-2022 (USD Billion)
Table A21: Germany Incretin Based Drugs Market, By Drug Type, By Value, 2023-2029 (USD Billion)
Table A22: Germany Incretin Based Drugs Market, By Route of Administration, By Value, 2019-2022 (USD Billion)
Table A23: Germany Incretin Based Drugs Market, By Route of Administration, By Value, 2023-2029 (USD Billion)
Table A24: Germany Incretin Based Drugs Market, By Indication, By Value, 2019-2022 (USD Billion)
Table A25: Germany Incretin Based Drugs Market, By Indication, By Value, 2023-2029 (USD Billion)
Table A26: United Kingdom Incretin Based Drugs Market, By Drug Type, By Value, 2019-2022 (USD Billion)
Table A27: United Kingdom Incretin Based Drugs Market, By Drug Type, By Value, 2023-2029 (USD Billion)
Table A28: United Kingdom Incretin Based Drugs Market, By Route of Administration, By Value, 2019-2022 (USD Billion)
Table A29: United Kingdom Incretin Based Drugs Market, By Route of Administration, By Value, 2023-2029 (USD Billion)
Table A30: United Kingdom Incretin Based Drugs Market, By Indication, By Value, 2019-2022 (USD Billion)
Table A31: United Kingdom Incretin Based Drugs Market, By Indication, By Value, 2023-2029 (USD Billion)
Table A32: France Incretin Based Drugs Market, By Drug Type, By Value, 2019-2022 (USD Billion)
Table A33: France Incretin Based Drugs Market, By Drug Type, By Value, 2023-2029 (USD Billion)
Table A34: France Incretin Based Drugs Market, By Route of Administration, By Value, 2019-2022 (USD Billion)
Table A35: France Incretin Based Drugs Market, By Route of Administration, By Value, 2023-2029 (USD Billion)
Table A36: France Incretin Based Drugs Market, By Indication, By Value, 2019-2022 (USD Billion)
Table A37: France Incretin Based Drugs Market, By Indication, By Value, 2023-2029 (USD Billion)
Table A38: Italy Incretin Based Drugs Market, By Drug Type, By Value, 2019-2022 (USD Billion)
Table A39: Italy Incretin Based Drugs Market, By Drug Type, By Value, 2023-2029 (USD Billion)
Table A40: Italy Incretin Based Drugs Market, By Route of Administration, By Value, 2019-2022 (USD Billion)
Table A41: Italy Incretin Based Drugs Market, By Route of Administration, By Value, 2023-2029 (USD Billion)
Table A42: Italy Incretin Based Drugs Market, By Indication, By Value, 2019-2022 (USD Billion)
Table A43: Italy Incretin Based Drugs Market, By Indication, By Value, 2023-2029 (USD Billion)
Table A44: Spain Incretin Based Drugs Market, By Drug Type, By Value, 2019-2022 (USD Billion)
Table A45: Spain Incretin Based Drugs Market, By Drug Type, By Value, 2023-2029 (USD Billion)
Table A46: Spain Incretin Based Drugs Market, By Route of Administration, By Value, 2019-2022 (USD Billion)
Table A47: Spain Incretin Based Drugs Market, By Route of Administration, By Value, 2023-2029 (USD Billion)
Table A48: Spain Incretin Based Drugs Market, By Indication, By Value, 2019-2022 (USD Billion)
Table A49: Spain Incretin Based Drugs Market, By Indication, By Value, 2023-2029 (USD Billion)
Table A50: Rest of Europe Incretin Based Drugs Market, By Drug Type, By Value, 2019-2022 (USD Billion)
Table A51: Rest of Europe Incretin Based Drugs Market, By Drug Type, By Value, 2023-2029 (USD Billion)
Table A52: Rest of Europe Incretin Based Drugs Market, By Route of Administration, By Value, 2019-2022 (USD Billion)
Table A53: Rest of Europe Incretin Based Drugs Market, By Route of Administration, By Value, 2023-2029 (USD Billion)
Table A54: Rest of Europe Incretin Based Drugs Market, By Indication, By Value, 2019-2022 (USD Billion)
Table A55: Rest of Europe Incretin Based Drugs Market, By Indication, By Value, 2023-2029 (USD Billion)
Table A56: China Incretin Based Drugs Market, By Drug Type, By Value, 2019-2022 (USD Billion)
Table A57: China Incretin Based Drugs Market, By Drug Type, By Value, 2023-2029 (USD Billion)
Table A58: China Incretin Based Drugs Market, By Route of Administration, By Value, 2019-2022 (USD Billion)
Table A59: China Incretin Based Drugs Market, By Route of Administration, By Value, 2023-2029 (USD Billion)
Table A60: China Incretin Based Drugs Market, By Indication, By Value, 2019-2022 (USD Billion)
Table A61: China Incretin Based Drugs Market, By Indication, By Value, 2023-2029 (USD Billion)
Table A62: Japan Incretin Based Drugs Market, By Drug Type, By Value, 2019-2022 (USD Billion)
Table A63: Japan Incretin Based Drugs Market, By Drug Type, By Value, 2023-2029 (USD Billion)
Table A64: Japan Incretin Based Drugs Market, By Route of Administration, By Value, 2019-2022 (USD Billion)
Table A65: Japan Incretin Based Drugs Market, By Route of Administration, By Value, 2023-2029 (USD Billion)
Table A66: Japan Incretin Based Drugs Market, By Indication, By Value, 2019-2022 (USD Billion)
Table A67: Japan Incretin Based Drugs Market, By Indication, By Value, 2023-2029 (USD Billion)
Table A68: India Incretin Based Drugs Market, By Drug Type, By Value, 2019-2022 (USD Billion)
Table A69: India Incretin
Global Metformin Hydrochloride Market Research Report 2024
Published: 08-Jan-2024 Price: US 2900 Onwards Pages: 104
Metformin hydrochloride is The raw material of finished product metformin hydrochloride drugs. That is The API metformin hydrochloride. Metformin Hydrochloride finished product is an oral antihyperglycemic drug used in The management of type 2-diabetes. Metformin hydrochloride (N, N-dimethylimidodicarbonimidic diamide hydrochloride) is not chemically or pharmacologically related to any other classes of oral antihyperglycemic agents.
Metformin hydrochloride is a white to off-white crystall......
Global Antidiabetic Sulphonylureas Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 04-Jan-2024 Price: US 3380 Onwards Pages: 112
Market Overview of Global Antidiabetic Sulphonylureas market:
According to our latest research, the global Antidiabetic Sulphonylureas market looks promising in the next 5 years. As of 2022, the global Antidiabetic Sulphonylureas market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years.
This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of t......
Global Insulin Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 101
According to our LPI (LP Information) latest study, the global Insulin market size was valued at US$ million in 2023. With growing demand in downstream market, the Insulin is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Insulin market. Insulin are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization......
Global Insulin API Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 116
According to our LPI (LP Information) latest study, the global Insulin API market size was valued at US$ 1707.6 million in 2023. With growing demand in downstream market, the Insulin API is forecast to a readjusted size of US$ 2101.4 million by 2030 with a CAGR of 3.0% during review period.
The research report highlights the growth potential of the global Insulin API market. Insulin API are expected to show stable growth in the future market. However, product differentiation, reducing co......
Global Glucagon Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 101
According to our LPI (LP Information) latest study, the global Glucagon market size was valued at US$ 543.9 million in 2023. With growing demand in downstream market, the Glucagon is forecast to a readjusted size of US$ 835.7 million by 2030 with a CAGR of 6.3% during review period.
The research report highlights the growth potential of the global Glucagon market. Glucagon are expected to show stable growth in the future market. However, product differentiation, reducing costs, and suppl......
Global Acarbose Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 95
According to our LPI (LP Information) latest study, the global Acarbose market size was valued at US$ 135.8 million in 2023. With growing demand in downstream market, the Acarbose is forecast to a readjusted size of US$ 165.9 million by 2030 with a CAGR of 2.9% during review period.
The research report highlights the growth potential of the global Acarbose market. Acarbose are expected to show stable growth in the future market. However, product differentiation, reducing costs, and suppl......
Global Insulin Glargine Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 77
According to our LPI (LP Information) latest study, the global Insulin Glargine market size was valued at US$ 6562.1 million in 2023. With growing demand in downstream market, the Insulin Glargine is forecast to a readjusted size of US$ 8722.5 million by 2030 with a CAGR of 4.1% during review period.
The research report highlights the growth potential of the global Insulin Glargine market. Insulin Glargine are expected to show stable growth in the future market. However, product differen......
Global Liraglutide Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 103
According to our LPI (LP Information) latest study, the global Liraglutide market size was valued at US$ million in 2023. With growing demand in downstream market, the Liraglutide is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Liraglutide market. Liraglutide are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply ch......
Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 96
According to our LPI (LP Information) latest study, the global Glucagon Like Peptide-1 (GLP-1) Agonists market size was valued at US$ 8624.4 million in 2023. With growing demand in downstream market, the Glucagon Like Peptide-1 (GLP-1) Agonists is forecast to a readjusted size of US$ 21310 million by 2030 with a CAGR of 13.8% during review period.
The research report highlights the growth potential of the global Glucagon Like Peptide-1 (GLP-1) Agonists market. Glucagon Like Peptide-1 (GL......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
